SEC Comment Letter for Adicet Bio, Inc. (ACET) (CIK 0001720580) (ACET) — Feb 11, 2019
Adicet Bio, Inc. (ACET) (CIK 0001720580)
Date: Feb. 11, 2019 · CIK: 0001720580 · Accession: 0000000000-19-001737
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229499
Letter
February 8, 2019 Chen Schor President and Chief Executive Officer resTORbio, Inc. 500 Boylston Street, 12th Floor Boston, Massachusetts 02116 Re:resTORbio, Inc. Registration Statement on Form S-3 Filed February 1, 2019 File No. 333-229499 Dear Mr. Schor: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Todd Schiffman at 202-551-3491 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
February 8, 2019
Chen Schor
President and Chief Executive Officer
resTORbio, Inc.
500 Boylston Street, 12th Floor
Boston, Massachusetts 02116
Re:resTORbio, Inc.
Registration Statement on Form S-3
Filed February 1, 2019
File No. 333-229499
Dear Mr. Schor:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Todd Schiffman at 202-551-3491 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance